HSE pays 47% more for 'brand name' drugs

A new survey has found that Ireland's Health Service is paying one-and-a-half times more than Britain for brand name medicines.

The study carried out for the Swedish pharmaceutical sector shows that Ireland pays more than any other Northern European country for drugs that are still under patent.

The survey found that the HSE pays 47% more than Britain's NHS for such "brand name" drugs.


More in this Section

Pamela Anderson calls on Taoiseach to 'pull up his stylish socks' and ban fur farming

Mary Lou McDonald favourite to take over Sinn Féin as contenders rule themselves out

Gardaí refuse to work at station in Sligo over 'unsafe' building condition

Data shows number of pupils completing the Leaving Cert at record level


Today's Stories

Book gives insight into sisters’ life in monastery

Main parties rule out governing with Sinn Féin

Families concerned over lack of progress in Garda inquiries

RTÉ employee alleged to have sought sex with underage girl

Lifestyle

Our divergent relationship with animals

Cork photographer in the frame for top prize

Battle of the bog: Those who fought for access to the bathroom

A towering achievement: Exploring Irish castles and beautiful buildings

More From The Irish Examiner